iBio, Inc. Files 8-K with Regulatory Disclosures
Ticker: IBIO · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1420720
| Field | Detail |
|---|---|
| Company | Ibio, Inc. (IBIO) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-disclosure, financials
TL;DR
iBio filed an 8-K on 6/24/25 covering Reg FD, other events, and financials.
AI Summary
On June 24, 2025, iBio, Inc. filed an 8-K report detailing several events. The company announced a Regulation FD Disclosure, indicating a public disclosure of material information. Additionally, the filing includes "Other Events" and "Financial Statements and Exhibits," suggesting updates on corporate activities and financial reporting.
Why It Matters
This 8-K filing signals important updates from iBio, Inc. to the public, potentially affecting investors' understanding of the company's current status and future outlook.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant information, but without specific details on the 'Other Events' or the nature of the Regulation FD disclosure, the immediate risk impact is uncertain.
Key Numbers
- 001-35023 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-2797813 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- iBio, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- June 24, 2025 (date) — Date of earliest event reported
FAQ
What specific information was disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure but does not specify the exact information released in this section.
What are the 'Other Events' mentioned in the filing?
The filing lists 'Other Events' as an item but does not provide details on what these events entail.
What is the purpose of including 'Financial Statements and Exhibits' in this 8-K?
This suggests that the filing includes updated financial information or exhibits relevant to the reported period or events.
When was iBio, Inc. incorporated?
iBio, Inc. was incorporated in Delaware.
What is the principal executive office address for iBio, Inc.?
The principal executive offices are located at 11750 Sorrento Valley Road, Suite 200, San Diego, California 92121.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding iBio, Inc. (IBIO).